Foamy Viruses pp 181-196 | Cite as

Human Infection with Foamy Viruses

Part of the Current Topics in Microbiology and Immunology book series (CT MICROBIOLOGY, volume 277)


Virtually all nonhuman primate species investigated thus far including prosimians, New World and Old World monkeys and apes all harbor distinct and species-specific clades of simian foamy virus (SFV). However, evidence supporting the existence of a human-specific foamy virus (FV) is not yet available. Early reports describing widespread infection of healthy and sick humans with FV could not be confirmed. In contrast, all FV infections documented in humans are of zoonotic origin


Amyotrophic Lateral Sclerosis Chronic Fatigue Syndrome Familial Mediterranean Fever Grave Disease African Green Monkey 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Ali M, Taylor GP, Pitman RJ, Parker D, Rethwilm A, Cheingsong-Popov R, Weber JN, Bieniasz PD, Bradley J, McClure MO (1996) No evidence of antibody to human foamy virus in widespread human populations. AIDS Res Hum Retrovir 12:14731483Google Scholar
  2. Achong BG, Mansell PWA, Epstein MA, Clifford P (1971) An unusual virus in cul-tures from a human nasopharyngeal carcinoma. J Nail Cancer Inst 46:299–302Google Scholar
  3. Achong BG, Epstein MA (1978) Preliminary seroepidemiological studies on the hu-man syncytial virus. J Gen Virol 40:175–181PubMedCrossRefGoogle Scholar
  4. Achong BG, Epstein MA (1983) Naturally occurring antibodies to the human syncytial virus in West Africa. J Med Virol 11:53–57PubMedCrossRefGoogle Scholar
  5. Baum KF (1992) Absence of antibody to human spumaretrovirus in patients with chronic fatigue syndrome. Clin Infect Dis 14:623–624CrossRefGoogle Scholar
  6. Bieniasz PD, Rethwilm A, Pitman R, Daniel MD, Chrystie I, McClure MO (1995) A comparative study of higher primate foamy viruses, including a new virus from a gorilla. Virology 207:217–228PubMedCrossRefGoogle Scholar
  7. Boneva RS, Grindon AJ, Orton SL, Switzer WM, Shamugam V, Hussain AI, Bhullor VB, Chamberland ME, Heneine W, Folks TM, Chapman LE (2002) Simian foamy virus infection in a blood donor. Transfusion 42:886–891PubMedCrossRefGoogle Scholar
  8. Brown J, Matthews AL, Sandstrom PA, Chapman LE (1998) Xenotransplantation and the risk of retroviral zoonosis. Trends Microbiol 6:411–415PubMedCrossRefGoogle Scholar
  9. Brown P, Nemo G, Gajdusek DC (1978) Human foamy virus: further characterization, seroepidemiology, and relationship to chimpanzee foamy viruses. J Infect Dis 137:421–427PubMedCrossRefGoogle Scholar
  10. Butera ST, Brown J, Callahan ME, Owen SM, Matthews AL, Weigner DD, Chapman LE, Sandstrom PA (2000) Survey of veterinary conference attendees for evidence of zoonotic infection by feline retroviruses. J Am Vet Assoc 217:1475–1479CrossRefGoogle Scholar
  11. Callahan ME, Switzer W, Matthews AL, Roberts B, Heneine W, Folks TM, Sandstrom PA (1999) Persistent zoonotic infection of a human with simian foamy virus in the absence of an Intact orf-2 accessory gene. J Virol 73:9619–9624PubMedGoogle Scholar
  12. Cameron KR, Birchall SM, Moses MA (1978) Isolation of foamy virus from patient with dialysis encephalopathy. Lancet II:796CrossRefGoogle Scholar
  13. Cordonnier A, Casella JF, Heidmann T (1995) Isolation of novel human endogenous retrovirus-like elements with foamy virus-related pol sequence. J Virol 69:5890–5897Google Scholar
  14. Debons-Guillemin MC, Valla J, Gazeau J, Wybier-Franqui J, Giron ML, Toubert ME, Canivet M, Périès J (1992) No evidence of spumaretrovirus infection markers in 19 cases of de Quervain’s thyroiditis. AIDS Res Hum Retrovir 8:1547PubMedCrossRefGoogle Scholar
  15. Gow JW, Simpson K, Schliephake A, Behan WM, Morrison LJ, Cavanagh H, Rethwilm A, Behan PO (1992) Search for retrovirus in the chronic fatigue syndrome. J Clin Pathol 45:1058–1061PubMedCrossRefGoogle Scholar
  16. Gunn WJ, Komaroff AL, Connell DB, Levine SM, Cheney PR (1993) Inability of retro-viral tests to identify persons with chronic fatigue syndrome. MMWR Morb Mortal Wkly Rep 42:189–190Google Scholar
  17. Hahn H, Baunach G, Bräutigam S, Mergia A, Neumann-Haefelin D, Daniel MD, McClure M, Rethwilm A (1994) Reactivity of primate sera to foamy virus Gag and Bet proteins. J Gen Virol 75:2635–2644PubMedCrossRefGoogle Scholar
  18. Heneine W, Woods TC, Sinha SD, Khan AS, Chapman LE, Schonberger LB, Folks TM (1994) Lack of evidence for infection with known human and animal retroviruses in patients with chronic fatigue syndrome. Clin Infect Dis 18 Suppl 1:121–125CrossRefGoogle Scholar
  19. Heneine W, Musey VC, Sinha SD, Landay A, Northrup G, Khabbaz R, Kaplan JE (1995) Absence of evidence for human spumaretrovirus sequences in patients with Graves’ disease. J Acquir Immun Defic Syndr Hum Retrovir 9:99–101CrossRefGoogle Scholar
  20. Heneine W, Switzer WM, Sandstrom P, Brown J, Shanmugam V, Schable CA, Khan A S; Lerche NW, Schweizer M, Neumann-Haefelin D, Chapman LE, Folks TM (1998) Identification of a human population infected with simian foamy virus. Nat Med 4:403–407PubMedCrossRefGoogle Scholar
  21. Herchenröder O, Renne R, Loncar D, Cobb EK, Murthy KK, Schneider J, Mergia A, Luciw PA (1994) Isolation, cloning, and sequencing of simian foamy viruses from chimpanzees (SFVcpz): High homology to human foamy virus (HFV). Virology 201:187–199PubMedCrossRefGoogle Scholar
  22. Hooks JJ, Gibbs CJ (1975) The foamy viruses. Bacteriol Rev 39:169–185PubMedGoogle Scholar
  23. Hunsmann G, Flügel RM, Walder R (1990) Retroviral antibodies in Indians. Nature 344:120CrossRefGoogle Scholar
  24. Lagaye S, Vexiau P, Morozov V, Guénebaut-Claudet V, Tobaly-Tapiero J, Canivet M, Cathelineau G, Périès J, Emanoil-Ravier R (1992) Human spumaretrovirus-related sequences in the DNA of leukocytes from patients with Graves disease. Proc Natl Acad Sci USA 89:10070–10074PubMedCrossRefGoogle Scholar
  25. Larsen RD, Rivera-Marrero CA, Ernst LK, Cummings RD, Lowe JB (1990) Frameshift and nonsense mutations in a human genomic sequence homologous to a murine UDP-Gal:beta-D-Gal(1,4)-D-G1cNAcalpha(1,3) -galactosyltransferase cDNA. J Biol Chem 265:7055–61PubMedGoogle Scholar
  26. Lee H, Kim S, Kang M, Kim W, Cho B J (1998) Prevalence of human foamy virus-related sequences in the Korean population. Biomed Sci 5:267–73CrossRefGoogle Scholar
  27. Loh PC, Matsuura F, Mizumoto C (1980) Seroepidemiology of human syncytial virus: antibody prevalence in the Pacific. Intervirology 13:87–90PubMedCrossRefGoogle Scholar
  28. Loh PC. Spumaviruses. In: Levy JA (ed) The Retroviridae, Plenum Press, New YorkGoogle Scholar
  29. Mahnke C, Kashaiya P, Rössler J, Bannert H, Levin A, Blattner WA, Dietrich M, Lu-ande J, Löchelt M, Friedman-Kien AE, Komaroff AL, Loh PC, Westarp ME, Flügel RM (1992) Human spumavirus antibodies in sera from African patients. Arch Vi-rol 123:243–253Google Scholar
  30. McClure MO, Erlwein 0 (1995) Foamy viruses—pathogenic or therapeutic potential. Rev Med Virol 5:229–237CrossRefGoogle Scholar
  31. Muller HK, Ball G, Epstein MA, Achong BG, Lenoir G, Levin A (1980) The prevalence of naturally occurring antibodies to human syncytial virus in East African populations. J Gen Virol 47:399–406PubMedCrossRefGoogle Scholar
  32. Nemo GJ, Brown PW, Gibbs CJ Jr, Gajdusek DC (1978) Antigenic relationship of hu-man foamy virus to the simian foamy viruses. Infect Immun 20.69–72PubMedGoogle Scholar
  33. Neumann-Haefelin D, Fleps U, Renne R, Schweizer M (1993) Foamy viruses. Intervi-rology 35:196–207Google Scholar
  34. Pyykkö I, Vesanen M, Asikainen K, Koskiniemi M, Airaksinen L, Vaheri A (1993) Human spumaretrovirus in the etiology of sudden hearing loss. Acta Otolaryngol 113:109–112PubMedCrossRefGoogle Scholar
  35. Pyykkö I, Vesanen M, Asikainen K, Koskiniemi M, Airaksinen L, Vaheri A (1994) Human spumaretrovirus in the etiology of sudden hearing loss. Acta Otolaryngol 114:224PubMedCrossRefGoogle Scholar
  36. Rösener M, Hahn H, Kranz M, Heeney J, Rethwilm A (1996) Absence of serological evidence for foamy virus infection in patients with amyotrophic lateral sclerosis. J Med Virol 48:222–226.PubMedCrossRefGoogle Scholar
  37. Rother RP, Fodor WL, Springhorn JP, Birks CW, Setter E, Sandrin MS, Squinto SP, Rollins SA (1995) A novel mechanism of retrovirus inactivation in human serum mediated by anti-alpha-galactosyl natural antibody. J Exp Med 182:1345–1355PubMedCrossRefGoogle Scholar
  38. Saib A, Périès J, de Thé H (1993) A defective human foamy provirus generated by pregenome splicing. EMBO J 12:4439–4444PubMedGoogle Scholar
  39. Saib A, Canivet M, Giron ML, Bolgert F, Valla J, Lagaye S, Périès J, de Thé H (1994) Human foamy virus infection in myasthenia gravis. Lancet 343:666PubMedCrossRefGoogle Scholar
  40. Sandstrom PA, Phan K, Switzer W, Chapman L, Heneine W, Folks TM (2000) Simian foamy virus infection among zoo keepers. Lancet 355:551–552PubMedCrossRefGoogle Scholar
  41. Schweizer M, Turek R, Reinhardt M, Neumann-Haefelin D (1994) Absence of foamy virus DNA in Graves’ disease. AIDS Res Hum Retrovir 10:601–605PubMedCrossRefGoogle Scholar
  42. Schweizer M, Turek R, Hahn H, Schliephake A, Netzer KO, Eder G, Reinhardt M, Rethwilm A, Neumann-Haefelin D (1995) Markers of foamy virus (FV) infections in monkeys, apes, and accidentally infected humans: Appropriate testing fails to confirm suspected FIT prevalence in man AIDS Res Hum Retrovir 11:161–170Google Scholar
  43. Schweizer M, Neumann-Haefelin D (1995) Phylogenetic analysis of primate foamy viruses by comparison of pol sequences. Virology 207:577–582PubMedCrossRefGoogle Scholar
  44. Schweizer M, Falcone V, Gänge J, Turek R, Neumann-Haefelin D (1997) Simian foamy virus isolated from an accidentally infected human individual. J Virol 71:4821–4824PubMedGoogle Scholar
  45. Schweizer M, Schleer H, Pietrek M, Liegibel J, Falcone V, Neuman-Haefelin D (1999) Genetic Stability of foamy viruses: Long-term study in an African green monkey population. J Virol 73:9256–9265PubMedGoogle Scholar
  46. Simonsen L, Heneine W, Sinha SD, Arenberg IK (1994) Absence of evidence for infection with the human spuma retrovirus in an outbreak of Meniere-like vertiginous illness in Wyoming, USA. Acta Oto-Laryngologica 114:223–224PubMedCrossRefGoogle Scholar
  47. Stancek D, Gressnerová M (1974) A viral agent isolated from a patient with subacute de Quervain type thyroiditis. Acta Virol 18:365Google Scholar
  48. Stancek D, Stanceková-Gressnerova M, Janotka M, Hnilica P, Oravec D (1975) Isolation and some serological and epidemiological data on the viruses recovered from patients with subacute thyroiditis de Quervain. Med Microbiol Immunol 161:133–144PubMedCrossRefGoogle Scholar
  49. Stancekova M, Stancek D, Ciampor F, Mucha V, Hnilica P (1976) Morphological, cytological and biological observations on viruses isolated from patients with subacute thyroiditis de Quervain. Acta Virol 20:183–188PubMedGoogle Scholar
  50. Svenningsson A, Lycke J, Svennerholm B, Gronowitz S, Andersen 0 (1992) No evidence for spumavirus or oncovirus infection in relapsing-remitting multiple sclerosis. Ann Neurol 32:711–714PubMedCrossRefGoogle Scholar
  51. Tamura N, Kira S (1995) Human foamy virus and familial Mediterranean fever in Japan. JAMA 274:1509PubMedCrossRefGoogle Scholar
  52. Tobaly-Tapiero J, Bittoun P, Neves M, Guillemin MC, Lecellier CH, Puvion-Dutilleul F, Gicquel B, Zientara S, Giron ML, de The H, Saib A (2000) Isolation and characterization of an equine foamy virus. J Virol 74:4064–4073PubMedCrossRefGoogle Scholar
  53. Von Laer D, Neumann-Haefelin D, Heeney JL, Schweizer M (1996) Lymphocytes are the major reservoir for foamy viruses in peripheral blood. Virology 221:240–244CrossRefGoogle Scholar
  54. Wallen WC, Sever JL, McFarlin DE, McFarland HF, Traub RG, Rentier B, Greenstein JI, and Moore PM (1979) Attempt to isolate infectious agent from bone-marrow of patients with multiple sclerosis. Lancet II:414–415CrossRefGoogle Scholar
  55. Weiss RA (1988) Foamy retroviruses: A virus in search of a disease. Nature 333:497498Google Scholar
  56. Werner J, Gelderblom H (1979) Isolation of foamy virus from patients with de Quer-vain thyroiditis. Lancet II:258–259CrossRefGoogle Scholar
  57. Westarp ME, Kornhuber HH, Rössler J, Flügel RM (1992) Human spuma retrovirus antibodies in amyotrophic lateral sclerosis. Neurol Psychiatr Brain Res 1:1–4Google Scholar
  58. Westarp ME, Bartmann P, Hoff-Jorgensen R, Clausen J, Rasmussen H, Kornhuber HH (1993a) Amyotrophe Lateralsklerose-Hinweise fur eine erhöhte antiretrovirale Seroreaktivitat ohne augenfallige Epidemiologie. Nervenarzt 64:384–389PubMedGoogle Scholar
  59. Westarp ME, Fuchs D, Bartmann P, Hoff-Jorgensen R, Clausen J, Wachter H, Kornhuber HH (1993b) Amyotrophic lateral sclerosis an enigmatic disease with B-cellular and anti-retroviral immune responses. Eur J Med 2:327–332PubMedGoogle Scholar
  60. Westarp ME, Westphal KP, Clausen J, Rasmussen HB, Hoff-Jorgensen R, Fohring B, Kornhuber HH (1993c) Retroviral interference with neuronotrophic signaling in human motor neuron disease? Clin Physiol Biochem 10.1–7PubMedGoogle Scholar
  61. Westarp ME, Bartmann P, Rossler J, Geiger E, Westphal KP, Schreiber H, Fuchs D, Westarp MP, Kornhuber HH (1993d) Antiretroviral therapy in sporadic adult amyotrophic lateral sclerosis. Neuroreport 4:819–822PubMedCrossRefGoogle Scholar
  62. Westarp ME, Foring B, Rasmussen H, Schraff S, Mertens T, Kornhuber HH (1994) Retroviral synthetic peptide serum antibodies in human sporadic amyotrophic lateral sclerosis. Peptides 15:207–214PubMedCrossRefGoogle Scholar
  63. Wick G, Grubeck-Loebenstein B, Trieb K, Kalischnig G, Aguzzi A (1992) Human foamy virus antigens in thyroid tissue of Graves’ disease patients. Int Arch Allergy Immunol 99:153–156PubMedCrossRefGoogle Scholar
  64. Wick G, Trieb K, Aguzzi A, Recheis H, Anderl H, Grubeck-Loebenstein B (1993) Pos-sible role of human foamy virus in Graves’ disease. Intervirology 35:101–107PubMedGoogle Scholar
  65. Winkler IG, Löchelt M, Levesque JP, Bodem J, Flügel RM, Flowers RLP (1997) A rapid streptavidin-capture ELISA specific for the detection of antibodies to feline foamy virus. J Immunol Meth 207:69–77CrossRefGoogle Scholar
  66. Winkler IG, Flügel RM, Löchelt M, Flower RLP (1998) Detection and molecular characterization of feline foamy virus serotypes in naturally infected cats. Virology 247:144–151PubMedCrossRefGoogle Scholar
  67. Winkler IG, Löchelt M, Flower RLP (1999) Epidemiology of feline foamy virus and feline immunodeficiency virus infections in domestic and feral cats: a seroepidemiological study. J Clin Micro 37:2848–2851Google Scholar
  68. Yanagawa T, Ito K, Kaplan EL, Ishikawa N, DeGroot LJ (1995) Absence of association between human spumaretrovirus and Graves’ disease. Thyroid 5:379–382PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2003

Authors and Affiliations

  1. 1.HIV and Retrovirology BranchCenters for Disease Control and PreventionAtlantaUSA
  2. 2.Paul-Ehrlich-InstitutLangenGermany
  3. 3.Bureau of HIV/AIDSSTD and TB, Health CanadaOttawaCanada

Personalised recommendations